
A recent study conducted in Germany evaluated the effectiveness of transcranial direct current stimulation (tDCS) as a supplementary treatment for major depressive disorder (MDD). The trial involved 150 adult patients with MDD who were receiving stable doses of selective serotonin reuptake inhibitors (SSRIs). Half of the participants received active tDCS while the other half received sham stimulation. After a 6-week period, no significant difference was observed in the improvement of depressive symptoms between the two groups. However, the active tDCS group experienced more mild adverse events compared to the sham group. These findings suggest that tDCS may not be an effective additional treatment for MDD when combined with SSRIs.
Like
Save
Share